$0.790100
-0.03-3.49%
At Close: -
$0.790100
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Karyopharm Therapeutics
KPTINASDAQ
Karyopharm Therapeutics (KPTI) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestKaryopharm Therapeutics (NASDAQ:KPTI) Stock Quotes, Forecast and News Summary
Karyopharm Therapeutics Stock (NASDAQ: KPTI) stock price, news, charts, stock research, profile.
| Open | $0.83 |
| Close | $0.79 |
| Volume / Avg. | 1.34M / 1.44M |
| Day Range | 0.79 - 0.85 |
| 52 Wk Range | 0.62 - 1.95 |
| Market Cap | $98.46M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 34 |
| Short Interest | 17.5% |
| Days to Cover | 17.49 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Karyopharm Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer the...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Karyopharm Therapeutics (KPTI) stock?
You can purchase shares of Karyopharm Therapeutics (NASDAQ:KPTI) through any online brokerage.
Who are Karyopharm Therapeutics (KPTI) competitors?
Other companies in Karyopharm Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Armata Pharmaceuticals (AMEX:ARMP), Vistagen Therapeutics (NASDAQ:VTGN), Tevogen Bio Holdings (NASDAQ:TVGN) and Eledon Pharma (NASDAQ:ELDN).
What is the target price for Karyopharm Therapeutics (KPTI) stock?
There is no analysis for Karyopharm Therapeutics.
What is the forecast for Karyopharm Therapeutics (KPTI) stock?
Karyopharm Therapeutics has a consensus price target of $8.64.
Current stock price for Karyopharm Therapeutics (KPTI)?
The stock price for Karyopharm Therapeutics (NASDAQ: KPTI) is $0.7901 last updated Today at July 8, 2024 at 4:00 PM EDT.
Does Karyopharm Therapeutics (KPTI) pay a dividend?
There are no upcoming dividends for Karyopharm Therapeutics.
When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?
Karyopharm Therapeutics’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
Is Karyopharm Therapeutics (KPTI) going to split?
There is no upcoming split for Karyopharm Therapeutics.
What sector and industry does Karyopharm Therapeutics (KPTI) operate in?
Karyopharm Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.